PAPER Matthews DG, Khorani M, Bobe G, Caruso M, Magana AA, Gray NE, Quinn JF, Stevens JF, Maier CS, Soumyanath A
SEARCH RESULTS
5515 RESULTS
PAPER Wise J
Lecanemab: European drug agency upholds decision to recommend Alzheimer's drug.
BMJ. 2025 Mar 3;388:r439. PubMed.PAPER Du X, Wang H, Liu S, Song Y, Chen X, Chen Z, Zhou R, Du J, Zhang W, Gao R, Li H, Zhang G, Mao X, Chang L, Wu Y
Astrocytic GluN2A alleviates sleep deprivation-induced elevation of Aβ through regulating neprilysin and AQP4 via the calcineurin/NFAT pathway.
Prog Neurobiol. 2025 Mar 1;:102744. Epub 2025 Mar 1 PubMed.PAPER Nieves J, Gil G, Gonzalez A
A bird's eye view to the homeostatic, Alzheimer and Glioblastoma attractors.
Heliyon. 2025 Feb 28;11(4):e42445. Epub 2025 Feb 4 PubMed.PSEN1 I162S
MUTATIONS PSEN1 73653565 GRCh37/hg19 rs1898533739 T G 73186857 GRCh38/hg38 T G Exon 6 Coding Unknown, but predicted deleterious in silico (PHRED-scaled CADD score = 26.0). Unknown. I162S Alzheimer's Disease: Not ClassifiedAlzheimer's Disease Detailed info
PSEN1 F118V
MUTATIONS PSEN1 73640287 GRCh37/hg19 T G 73173579 GRCh38/hg38 T G Exon 5 Coding Increased the Aβ42/Aβ40 ratio due to reduced Aβ40 production in cells. Unknown. F118V Alzheimer's Disease: Not ClassifiedAlzheimer's Disease Detailed information on carrier(s)
PSEN1 F105S
MUTATIONS PSEN1 73171023 GRCh37/hg19 T C 73637731 GRCh38/hg38 T C Exon 4 Coding Unknown, but predicted deleterious in silico (PHRED-scaled CADD score = 27.1). Unknown. F105S Alzheimer's Disease: Not ClassifiedAlzheimer's Disease This variant was identifie
PAPER Gordon I, Genis I, Grauer E, Sehayek E, Michaelson DM
Biochemical and cognitive studies of apolipoprotein-E-deficient mice.
Mol Chem Neuropathol. 1996;28(1-3):97-103. PubMed.PAPER Gordon I, Grauer E, Genis I, Sehayek E, Michaelson DM
Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice.
Neurosci Lett. 1995 Oct 13;199(1):1-4. PubMed.PAPER Ueno H, Takahashi Y, Mori S, Kitano E, Murakami S, Wani K, Miyazaki T, Matsumoto Y, Okamoto M, Ishihara T
Age-related behavioural abnormalities in C57BL/6.KOR-Apoe shl mice.
Transl Neurosci. 2025 Jan 1;16(1):20220363. Epub 2025 Feb 25 PubMed.PSEN1 V97M
MUTATIONS PSEN1 73637706 GRCh37/hg19 rs63750852 G A 73170998 GRCh38/hg38 G A Exon 4 Coding Unknown. V97M Alzheimer's Disease: Not ClassifiedAlzheimer's Disease This variant was identified in France in individual(s) who developed Alzheimer’s disease (AD) (
European Brain Barriers Meeting- 27th
CONFERENCE 2025-09-08 00:00:00-2025-09-10 00:00:00 Bern, Switzerland 08 – 10 September 2025 View Conference Website 0
Barcelona Blood-Brain Barrier Conference- B4 2025
CONFERENCE 2025-10-01 00:00:00-2025-10-03 00:00:00 Barcelona, Spain 01 – 03 October 2025 View Conference Website 0
CSH Asia: Stem cell, Aging and Rejuvenation
CONFERENCE 2025-09-15 00:00:00-2025-09-19 00:00:00 Suzhou, China 15 – 19 September 2025 View Conference Website 0
PAPER Strijkert F, Scheenen ME, Huitema RB, van den Berg E, van Munster BC, Spikman JM
Comment on: "Neuropsychiatric Presentations of Common Dementia Syndromes: A Concise Review for Primary Care Team Members".
J Am Geriatr Soc. 2025 Mar 7; Epub 2025 Mar 7 PubMed.Current Filters
- Date Range : Dec 2024 to Mar 2025 x